45182
Enterotoxin B from Staphylococcus aureus
≥95% (GE)
Synonym(s):
SEB, Staphylococcal enterotoxin B
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
UNSPSC Code:
12352200
MDL number:
Product Name
Enterotoxin B from Staphylococcus aureus, ≥95% (GE)
assay
≥95% (GE)
mol wt
Mr ~29000
concentration
~25% protein
impurities
Sodium phosphate
solubility
H2O: 4 mg/mL, clear, colorless
storage temp.
2-8°C
Looking for similar products? Visit Product Comparison Guide
flash_point_c
Not applicable
Storage Class
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
Regulatory Information
高风险级别生物产品--毒素类产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Purification of staphylococcal enterotoxins.
J J Iandolo et al.
Methods in enzymology, 165, 43-52 (1988-01-01)
Susanna Lopez Kostka et al.
Journal of immunology (Baltimore, Md. : 1950), 182(5), 3039-3046 (2009-02-24)
Resistance to leishmaniasis in C57BL/6 mice depends on Th1/Tc1 cells. BALB/c mice preferentially develop Th2 immunity and succumb to infection. We now assessed the role of IL-17 in cutaneous leishmaniasis. During the course of Leishmania major infection, BALB/c CD4 cells
Alexandra Schuetz et al.
PloS one, 6(11), e27284-e27284 (2011-11-17)
The level of bacterial activity is only poorly defined during asymptomatic Mycobacterium tuberculosis (MTB) infection. The objective was to study the capacity of a new biomarker, the expression of the T cell maturation marker CD27 on MTB-specific CD4 T cells
Marla Lay et al.
Vaccine, 27(29), 3811-3820 (2009-05-02)
Safe and effective adjuvants for influenza vaccines that could increase both the levels of neutralizing antibody, including against drifted viral subtypes, and T-cell immunity would be a major advance in vaccine design. The JVRS-100 adjuvant, consisting of DOTIM/cholesterol cationic liposome-DNA
Xiao-Li Huang et al.
Clinical and vaccine immunology : CVI, 16(10), 1504-1516 (2009-08-21)
Human immunodeficiency virus type 1 (HIV-1)-specific T-cell reactivity has been related to protection from disease progression. Optimal T-cell reactivity to HIV-1 presumably requires antigen processing and presentation by professional antigen-presenting cells, particularly dendritic cells (DC). Here we examined whether multiple
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service